2EyesVision receives two key honors at the Biophotonics for Eye Research conference in Granada, spotlighting the role of SimVis Gekko in improving IOL selection and patient care

Granada, Spain – Innovation in ophthalmology goes beyond devices—it’s about improving decisions that impact patient outcomes. At BER2025 – Biophotonics for Eye Research, held June 4–6 in Granada, Spain, 2EyesVision received two major recognitions for its contributions to the field of visual simulation and intraocular lens (IOL) selection. These honors highlight the growing scientific validation of SimVis Gekko and its value in clinical and surgical planning. SimVis Gekko is a binocular visual simulator that enables patients and surgeons to preview the visual outcomes of different IOLs—before surgery. This real-time, real-world simulation offers a personalized experience that helps assess visual function, manage expectations, and educate patients on the impact of multifocal, monofocal, or EDOF lenses. Unlike virtual reality or static tools, SimVis Gekko delivers dynamic optical accuracy with clinical relevance.

At this year’s BER2025, two researchers from 2EyesVision were recognized for their outstanding contributions:

• Alejandra Varea received a Travel Grant for her work on validating clinical applications of SimVis.
• Petros Papadogiannis was awarded Best Poster for his study on halo size evaluation using SimVis Gekko.

“These recognitions not only reflect the quality of our team’s work, but also the impact of SimVis Gekko in advancing personalized visual care,” said Dr. Carlos Dorronsoro, CEO of 2EyesVision.

SimVis Gekko is helping ophthalmologists worldwide empower patients and improve surgical outcomes. Contact us to learn how this solution can enhance your preoperative workflow.

Are you looking for a way to personalize IOL selection and reduce uncertainty in surgical outcomes?

Discover how SimVis Gekko can help you deliver a more transparent, patient-centered preoperative experience—grounded in real vision, not estimates. Contact our team to explore the solution.